Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

LHC Group Inc (LHCG)

LHC Group Inc (LHCG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

LHC Group Inc 901 HUGH WALLIS ROAD SOUTH LAFAYETTE LA 70508 USA

www.lhcgroup.com P: 337-233-1307

Description:

LHC Group serves as a post-acute care partner for hospitals, physicians and families in the U.S. From home health and hospice care to long-term acute care and community-based services, it delivers high-quality, cost-effective care that helps patients manage their health at home. The company operates through 5 segments: home health, hospice, home and community-based, facility-based and healthcare innovation. Its home health service locations offer a wide range of services, including skilled nursing, medically-oriented social services and physical, occupational and speech therapy. Hospices provide end-of-life care to patients with terminal illnesses through interdisciplinary teams of physicians, nurses, home health aides, counselors and volunteers. The home and community-based services offer assistance with activities of daily living to elderly, chronically ill, and disabled patients. The healthcare innovations segment reports on the company's developmental activities outside its other business segments.

Key Statistics

Overview:

Market Capitalization, $K 5,269,714
Enterprise Value, $K 5,938,604
Shares Outstanding, K 31,033
Annual Sales, $ 2,220 M
Annual Net Income, $ 115,730 K
Last Quarter Sales, $ 576,910 K
Last Quarter Net Income, $ 17,310 K
60-Month Beta 0.43
% of Insider Shareholders 4.80%
% of Institutional Shareholders 83.47%
Float, K 29,543
% Float 95.20%
Short Volume Ratio 0.34

Growth:

1-Year Return 35.63%
3-Year Return 39.81%
5-Year Return 178.10%
5-Year Revenue Growth 142.63%
5-Year Earnings Growth 175.48%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.06 on 11/02/22
Latest Earnings Date 02/22/23
Earnings Per Share ttm 4.39
EPS Growth vs. Prev Qtr 8.16%
EPS Growth vs. Prev Year -26.90%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

LHCG Ratios

Ratio
Price/Earnings ttm 38.50
Price/Earnings forward 35.24
Price/Earnings to Growth 22.73
Return-on-Equity % 8.13%
Return-on-Assets % 4.63%
Profit Margin % 5.21%
Debt/Equity 0.44
Price/Sales 2.28
Price/Cash Flow 22.60
Price/Book 3.13
Book Value/Share 54.32
Interest Coverage 42.77
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar